26 November 2025 – The EUCAIM Public Webinar held today brought together patients, caregivers, healthcare professionals, and the general public, creating a unique space where
Cancer remains one of Europe’s greatest health challenges, and collaboration is key to accelerating progress in early detection and treatment. The Cancer Image Europe, alongside
The EUCAIM Project and Cancer Image Europe are presented at the European Society of Radiology Annual Leadership Meeting 2025 in Cannes, France.
We are pleased to announce that the EUCAIM Lay Summary is now available. This accessible overview highlights the project’s goals, achievements, and progress in advancing
Date: 26 November 2025Time: 11:00 – 12:00 CET The European Federation for Cancer Images (EUCAIM) invites patients, caregivers, healthcare professionals, and the general public to
EUCAIM is pleased to announce that Poland, Cyprus, and Estonia have joined the growing group of EU Member States supporting the establishment of the EUCAIM
We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.
Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.
Apply by 10 June 2024!
We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.
EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.
Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.
Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.